🔥🐔 BizChicken 🐔🔥
Companies Similar to Aprea Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Alnylam Pharmaceuticals, Inc.
ONPATTRO
Alnylam Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. It targets genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and CNS/ocular diseases.
About | Leadership | DEI | About | About | About | About | About | About | Contact | Careers | Careers | Careers | Careers | Jobs | News | News | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Culture | Jobs | About | News | News | News | News | Careers | News | News | Careers | About | About | About | About | About | About | About | Jobs | About
Symbol: ALNY
Recent Price: $236.01
Industry: Biotechnology
CEO: Dr. Yvonne L. Greenstreet M.B.A., MBChB
Sector: Healthcare
Employees: 2100
Address: 675 West Kendall Street, Cambridge, MA 02142
Phone: 617 551 8200
Leadership
- Yvonne Greenstreet, Chief Executive Officer
- Pushkal Garg, Chief Medical Officer
- Jeff Poulton, Chief Financial Officer
- Kelley Boucher, Chief Human Resource Officer
- Timothy Maines, Chief Technical Operations and Quality Officer
- Tolga Tanguler, Chief Commercial Officer
- Piyush Sharma, Chief Ethics & Compliance Officer
- Evan Lippman, Chief Corporate Development & Strategy Officer
- Kevin Fitzgerald, Chief Scientific Officer
- Amy W. Schulman, Chair
- Dennis A. Ausiello,
- Carolyn Bertozzi,
- Michael W. Bonney,
- Olivier Brandicourt,
- Margaret A. Hamburg,
- Peter N. Kellogg,
- David E.I. Pyott,
- Colleen F. Reitan,
- Phillip A. Sharp,
- Elliott Sigal,
Last updated: 2024-12-31
Allarity Therapeutics, Inc.
Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.
Careers | Careers | Careers | About | About | About | About | About | About | About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: ALLR
Recent Price: $1.12
Industry: Biotechnology
CEO: Mr. Thomas H. Jensen
Sector: Healthcare
Employees: 5
Address: 210 Broadway, Cambridge, MA 02139
Phone: 401 426 4664
Last updated: 2024-12-31
Applied Therapeutics, Inc.
AT-007
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.
About | Leadership | Leadership | Leadership | Leadership | Vision/Values | Culture | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: APLT
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Sector: Healthcare
Employees: 31
Address: 545 Fifth Avenue, New York, NY 10017
Phone: 212 220 9226
Leadership
- Shoshana Shendelman, Chair, Board of Directors
- Riccardo Perfetti, Chief Medical Officer
- Les Funtleyder,
- Dale Hooks, Chief Commercial Officer
- Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
- Joel Marcus,
- Jay Skyler,
- Stacy Kanter,
- Teena Lerner,
- Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
- Roy Freeman M.D.,
- Roxana Mehran M.D.,
- Lawrence Steinman M.D.,
- Gregg Stone M.D.,
- Donald d'Amico M.D.,
- Donald Landry, Chair, Scientific Advisory Board
- Roy Freeman,
- Roxana Mehran,
- Lawrence Steinman,
- Gregg Stone,
- Donald d'Amico,
Last updated: 2024-12-31
Arrowhead Pharmaceuticals, Inc.
ARO-AAT, ARO-APOC3, ARO-ANG3, ARO-HSD, ARO-ENaC, ARO-C3, ARO-Lung2, ARO-DUX4, ARO-XDH
Arrowhead Pharmaceuticals, Inc. develops medicines for intractable diseases, with products including RNAi therapeutics addressing liver diseases, hypertriglyceridemia, and various other conditions in different trial phases.
Symbol: ARWR
Recent Price: $18.61
Industry: Biotechnology
CEO: Dr. Christopher R. Anzalone Ph.D.
Sector: Healthcare
Employees: 525
Address: 177 East Colorado Boulevard, Pasadena, CA 91105
Phone: 626 304 3400
Leadership
- Christopher Anzalone, PhD,
- James Hamilton, MD, MBA, Chief of Discovery and Translational Medicine
- Ken Myszkowski, MBA, CPA, Chief Financial Officer
- Patrick O’Brien, PharmD, JD, Chief Operating Officer and General Counsel
- Tracie Oliver, MSc, MBA, Chief Commercial Officer
- Douglass Given, MD, PhD, MBA, Chairman
- Mauro Ferrari, PhD,
- Michael Perry, DVM, PhD,
- William Waddill,
- Oye Olukotun, MD, MPH,
- Victoria Vakiener,
- Hongbo Lu, PhD, MBA,
Last updated: 2024-12-31
Atea Pharmaceuticals, Inc.
AT-527
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics for viral infections, with a lead product candidate AT-527 for COVID-19 treatment.
Symbol: AVIR
Recent Price: $3.33
Industry: Biotechnology
CEO: Dr. Jean-Pierre Sommadossi Ph.D.
Sector: Healthcare
Employees: 75
Address: 125 Summer Street, Boston, MA 02110
Phone: 857 284 8891
Leadership
- Jean-Pierre Sommadossi, PhD, FOUNDER, CHAIRMAN & CEO
- Nancy Agrawal, PhD, Executive VP, Preclinical Development
- Jonae Barnes, Senior VP, Investor Relations & Corporate Communications
- Bruce Belanger, PhD, Senior VP, Biostatistics
- Andrea Corcoran, CFO & Executive VP, Legal
- Adam DeZure, MD, VP, Clinical Development
- James MB Evans, PhD, VP, CMC Manufacturing
- Wayne Foster, EXECUTIVE VP, Chief Accounting Officer
- Kerry Gagnon, VP, Head of Quality
- Steven Good, EXECUTIVE VP, PRECLINICAL SCIENCE
- Janet Hammond, MD, PhD, CHIEF DEVELOPMENT OFFICER
- Arantxa Horga, MD, Chief Medical Officer
- Qi Huang, Senior VP, Virology
- Laura Ishak, Senior VP, Clinical Operations
- Ariyapadi Krishnaraj, VP, Marketing
- Adel Moussa, PhD, EXECUTIVE VP, CHEMISTRY
- Shari Noble, VP, Deputy General Counsel
- Keith Pietropaolo, Executive VP, Clinical Sciences and Project Management
- Brian Rowe, VP, Business Development
- Marc Van Hulle, VP, Finance
- John Vavricka, CHIEF COMMERCIAL OFFICER
- Alex Vo, PhD, VP, DMPK
- Jayanthi Wolf, PhD, Executive VP, Regulatory Affairs
- Xiao-Jian Zhou, PhD, EXECUTIVE VP, EARLY STAGE DEVELOPMENT
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Acrivon Therapeutics, Inc. Common Stock
Acrivon Predictive Precision Proteomics
Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines using a proteomics-based platform to identify patient responders. Their lead candidate, ACR-368, is in Phase 2 trials for various cancers.
Symbol: ACRV
Recent Price: $5.41
Industry: Biotechnology
CEO: Dr. Peter Blume-Jensen M.D., Ph.D.
Sector: Healthcare
Employees: 58
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617-207-8979
Last updated: 2024-12-31
Aileron Therapeutics, Inc.
ALRN-6924
Aileron Therapeutics, Inc. is a clinical stage oncology company developing ALRN-6924 for various cancer treatments, with multiple clinical trials in progress.
Symbol: ALRN
Recent Price: $2.32
Industry: Biotechnology
CEO: Dr. James Brian Windsor Ph.D.
Sector: Healthcare
Employees: 15
Address: 285 Summer Street, Boston, MA 02210
Phone: 617 995 0900
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
Aprea Therapeutics, Inc.
ATRN-119
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors.
Symbol: APRE
Recent Price: $3.48
Industry: Biotechnology
CEO: Dr. Oren Gilad Ph.D.
Sector: Healthcare
Employees: 7
Address: 535 Boylston St., Boston, MA 02116
Phone: 617-463-9385
Last updated: 2024-12-31
Atossa Therapeutics, Inc.
Endoxifen
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for oncology and infectious diseases with key programs in breast cancer and COVID-19 treatment.
Symbol: ATOS
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.
Sector: Healthcare
Employees: 12
Address: 107 Spring Street, Seattle, WA 98104
Phone: 206 588 0256
Last updated: 2024-12-31
Atara Biotherapeutics, Inc.
T-cell immunotherapy treatments
Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.
About | About | About | Contact | About | Careers | Careers | About | Careers | Careers | About | About
Symbol: ATRA
Recent Price: $13.28
Industry: Biotechnology
CEO: Dr. Anhco Nguyen Ph.D.
Sector: Healthcare
Employees: 165
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 650 278 8930
Last updated: 2024-12-31
Astria Therapeutics, Inc.
STAR-0215
Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.
Symbol: ATXS
Recent Price: $8.88
Industry: Biotechnology
CEO: Ms. Jill C. Milne Ph.D.
Sector: Healthcare
Employees: 59
Address: 100 High Street, Boston, MA 02110
Phone: 617 349 1971
Last updated: 2024-12-31
Context Therapeutics Inc.
onapristone extended release (ONA-XR)
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments for women in the United States. Its main product, ONA-XR, is aimed at resistant female hormone-dependent cancers.
Symbol: CNTX
Recent Price: $1.06
Industry: Biotechnology
CEO: Mr. Martin A. Lehr
Sector: Healthcare
Employees: 5
Address: 2001 Market Street, Philadelphia, PA 19103
Phone: 267 225 7416
Last updated: 2024-12-31
Intellia Therapeutics, Inc.
NTLA-2001, NTLA-2002, NTLA-5001
Intellia Therapeutics, Inc. is a genome editing company specializing in developing therapeutics, with a focus on in vivo and ex vivo programs, including treatments for transthyretin amyloidosis, hereditary angioedema, and acute myeloid leukemia. The company also develops engineered cell therapies and offers CRISPR/Cas9 tools.
News | About | About | Contact | Careers | Culture | DEI | Careers | Careers | Careers | Culture | Jobs | Jobs | Careers | Careers | Careers | Jobs | About | About | About
Symbol: NTLA
Recent Price: $11.41
Industry: Biotechnology
CEO: Dr. John M. Leonard M.D.
Sector: Healthcare
Employees: 526
Address: 40 Erie Street, Cambridge, MA 02139
Phone: 857 285 6200
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Larimar Therapeutics, Inc.
CTI-1601
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for rare diseases using a novel cell penetrating peptide technology platform. Their lead product candidate, CTI-1601, is undergoing Phase 1 clinical trials to treat Friedreich's ataxia.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | About | About | About | Careers
Symbol: LRMR
Recent Price: $3.91
Industry: Biotechnology
CEO: Dr. Carole S. Ben-Maimon M.D.
Sector: Healthcare
Employees: 42
Address: Three Bala Plaza East, Bala Cynwyd, PA 19004
Phone: 844 511 9056
Leadership
- Carole Ben-Maimon, MD, President and Chief Executive Officer
- Gopi Shankar, PhD, MBA, FAAPS, Chief Development Officer
- Rusty Clayton, DO, Chief Medical Officer
- Michael Celano, CHIEF FINANCIAL OFFICER
- John Berman, Vice President of Finance and Administration
- Jennifer Johansson, Vice President, Legal and Compliance
- Keith E. Lynch, Jr., Vice President, CMC Technical Operations
- Noreen Scherer, Vice President of Clinical Operations
- Francis Michael Conway, CPA, VICE PRESIDENT AND CONTROLLER
- Mohamed Hamdani, Vice President, Statistics and Quantitative Sciences
- Adrienne Clements-Egan, Ph.D., Vice President, Bioanalytics and Developability
- Frank Nazzario, RPh, Vice President, Commercial
- Joseph Truitt, BOARD CHAIR
- Tom Hamilton,
- Jonathan Leff,
- Frank E. Thomas,
- Jeffrey Sherman, MD,
- ,
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08